44'-DDE

CAS No. 72-55-9

44'-DDE( pp'-DDE | Dichlorodiphenyldichloroethylene | pp'-dichlorodiphenyldichloroethylene )

Catalog No. M20819 CAS No. 72-55-9

44'-DDE is a metabolite and degradation product of the organochlorine pesticide DDT.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG 32 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    44'-DDE
  • Note
    Research use only, not for human use.
  • Brief Description
    44'-DDE is a metabolite and degradation product of the organochlorine pesticide DDT.
  • Description
    44'-DDE is a metabolite and degradation product of the organochlorine pesticide DDT.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    pp'-DDE | Dichlorodiphenyldichloroethylene | pp'-dichlorodiphenyldichloroethylene
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    Androgen Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    72-55-9
  • Formula Weight
    318
  • Molecular Formula
    C14H8Cl4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:63mg/mL(198.09mM)
  • SMILES
    ClC(Cl)=C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Matthews J Celius T Halgren R et al. Differential estrogen receptor binding of estrogenic substances: A species comparison[J]. The Journal of Steroid Biochemistry and Molecular Biology 2000 74(4):223-234.
molnova catalog
related products
  • Adrenosterone

    Adrenosterone is a steroid hormone with weak androgenic effect.

  • Boldenone undecylena...

    A synthetic, anabolic-androgenic steroid (AAS) and androgen ester that is used in veterinary medicine, a long-acting ester of boldenone.

  • 2-hydroxy Flutamide

    2-hydroxy Flutamide is competitive inhibition of androgen receptor (AR)?for the treatment of prostate cancer.